Last reviewed · How we verify
NCT06666868
CARD for Community Pharmacy Vaccinations - Phase 2
NA trial testing Sustained CARD in Vaccination in 500 participants. Not yet recruiting.
31 March 2025
Quick facts
| Lead sponsor | University of Toronto |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 500 |
| Start date | 5 November 2024 |
| Primary completion | 31 March 2025 |
| Estimated completion | 31 August 2025 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Sustained CARD
- First-time CARD
Conditions studied
- Vaccination — all drugs for Vaccination →
- Vaccination Pain — all drugs for Vaccination Pain →
- Vaccination Reaction — all drugs for Vaccination Reaction →
- Vaccination Pharmacy — all drugs for Vaccination Pharmacy →
Sponsor
University of Toronto
Who can join
Eligibility, any sex, with Vaccination or Vaccination Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is phase 2 of a cluster trial integrating the CARD (Comfort Ask Relax System) in community pharmacies affiliated with Wholehealth Pharmacy Partners. It involves continuing CARD in pharmacies randomized to CARD in phase 1 of the trial (2023-2024 fall/winter vaccination season), and initiating CARD in pharmacies randomized to Control (usual care) in phase 1 of the trial. Both groups will use CARD for delivery of vaccinations during the 2024-2025 fall/winter vaccination season.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06666868
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vaccination
Currently open trials in the same condition.
- NCT07236034 — ARISe at UMass Chan · NA · recruiting
- NCT07240558 — Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial) · Phase 3 · recruiting
- NCT07261280 — Testing a Biometric Identification System to Improve Malaria Vaccine Completion · NA · recruiting
- NCT07372950 — Kaiser Colorado Flu Nudge · NA · active not recruiting
- NCT07085611 — Neutralizing Power of Serum Antibodies - 2 · NA · recruiting
Other University of Toronto trials
Trials by the same sponsor.
- NCT07184255 — Animated Video Education for Retinal Surgery · NA · not yet recruiting
- NCT07259434 — Time Restricted Eating in Survivors Trial 2.0 · NA · not yet recruiting
- NCT07486050 — The Impact of Social Worker Referrals on Diabetes and Loneliness · NA · active not recruiting
- NCT07268729 — Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders · not yet recruiting
- NCT07317921 — Validating IAAO for Muscle Outcomes · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06666868 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Toronto
- Last refreshed: 31 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06666868.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing